The Treatment of Glaucoma: Role of β-Blocking Agents

Drugs - Tập 18 - Trang 25-32 - 2012
William P. Boger1
1Department of Ophthalmology, Harvard Medical School, Children’s Hospital Medical Center and Massachusetts Eye and Ear Infirmary, Boston, USA

Tóm tắt

The sudden development of a red painful eye with blurred vision may be an acute attack of angle closure glaucoma which requires emergency attention. Once the attack is controlled with medication, surgical intervention with a peripheral iridectomy is indicated to relieve relative pupillary block. Eyes subject to angle closure glaucoma are anatomically different with ‘crowded’ anterior segments. In contrast, open angle glaucoma (the more common form) may progress to near blindness without symptoms. Routine screening of intraocular pressure is, therefore, necessary to make the diagnosis before extensive irreparable damage has occurred. Surgery for open angle glaucoma carries risks of cataract and infection, and is unpredictable. Open angle glaucoma patients are usually treated chronically with specific medications. β-Adrenoceptor blocking agents appear to provide a significant new addition to the currently available antiglaucoma medications.

Tài liệu tham khảo

Banziger, Th.: The mechanism of acute glaucoma and the exploration for the effectiveness of iridectomy for the same. Berichte Deutsch. OphthaJ. Ges. 43: 43–48 (1922). Bietti, G.: Recent experimental, clinical, and therapeutic research on the problems of intraocular pressure and glaucoma. American Journal of Ophthalmology 73i 475–500 (1972a). Bietti, G.: Weitere beitrage zurc Deutung und Behandlung des Glaukons. Klinische Monatsblatt Augenheilkunde 162: 281–289 (1972b). Brenkman, R.F.: Long-term hypotensive effect of atenolol 4% eyedrops. Brit. J. Ophthalmol. 62: 287–291 (1978). Boger, W.P. III; Puliafito, CA.; Steinert, R.F. and Pavan-Langston, D.: Long-term experience with timolol ophthalmic solution in patients with open angle glaucoma. Transactions of the American Academy of Ophthalmology and Otolaryngology 85: 259–267 (1978a). Boger, W.P. III; Steinen, R.F.; Puliafito, C.A. and Pavan-Langston, D.: A ten-week double-masked clinical trial comparing timolol ophthalmic solution to pilocarpine in open angle glaucoma. American Journal of Ophthalmology 86: 8–18 (1978b). Bonomi, L. and Steindler, P.: Effect of pindolol on intraocular pressure. Brit. J. Ophthalmol. 59: 301–303 (1975). Bucci, M.G.; Giraldi, J.P.; Missiroli, A. and Virno, M.: La somministrazione locale del propranololo nella terapia del glaucoma. Bollettino d’Oculistica 47: 51–60 (1968). Bucci, M.G. and Romani, E.: Indagine tonografica sull’azione ipotonizzante oculare del propranololo. Bollettino d’Oculistica 51: 255–261 (1972). Bucci, M.G.; Stadelmann, C; Stirpe, M. and Grenga, R.: Azione ipotonizzante oculare del propranololo a varie concentrazioni. Bollettino d’Oculistica 51: 185–192 (1972). Chandler, P.A. and Grant, W.M.: in Lectures on Glaucoma (Lea and Febiger, Philadelphia 1968). Elliott, MJ.; CuUen, P.M. and Phillips, C.I.: Ocular hypotensive effect of atenolol (Tenormin ICI). A new beta-adrenergic blocker. Brit. J. Ophthalmol. 59: 296–300 (1975). Hagedoorn, A. and Tjoa, ST.: Practolol in the control of intraocular tension. Lancet 1: 733 (1974). Katz, I.M.; Hubbard, W.A.; Getson, A.J. and Gould, A.L.: Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Investigational Ophthalmology 15: 489–492 (1976). MacDonald, M J.; Cullen, P.M. and Phillips, C.I.: Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose. Brit. J. Ophthalmol. 60: 789–791 (1976). MacDonald, M.J.; Gore, S.M.; CuUen, P.M. and Phillips, C.I.: Comparison of ocular hypotensive effects of acetazolamide and atenolol. Brit. J. Ophthalmol. 61: 345–348 (1977). Phillips, C.I.; Howitt, G. and Rowlands, DJ.: Propranolol as ocular hypotensive agent. British Journal of Ophthalmology 51: 222–226 (1967). Phillips, C.I.; Gore, S.M.; MacDonald, M.J. and Cullen, P.M.: Atenolol eye drops in glaucoma: A double-masked, controlled study. British Journal of Ophthalmology 61: 349–353 (1977). Phillips, C.I.; Gore, S.M. and Gunn, P.M.: Atenolol versus adrenaline eye drops and an evaluation of these two combined. British Journal of Ophthalmology 62: 296–301 (1978). Sharef, E.; Haroun, E.A.; Ishaac, Z.; El-Shewy, T.M. and Nassef, A.: The effect of some beta-adrenergic blockers on human intraocular pressure. Experimental Eye Research 19: 223–225 (1974). Vale, J. and Phillips, C.I.: Practolol (Eraldin) eye drops as an ocular hypotensive agent. British Journal of Ophthalmology 57: 210–214 (1973). WettreU, K. and Pandolfi, M.: Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Experimental Eye Research 21: 451–456 (1975). WettreU, K. and Pandolfi, M.: Effect of topical atenolol on intraocular pressure. British Journal of Ophthalmology 61: 334–338 0977). WettreU, K.; Wilke, K. and Pandolfi, M.: Topical atenolol versus pilocarpine: A double-blind study of the effect on ocular tension. British Journal of Ophthalmology 62: 292–295 (1978). Zimmerman, TJ. and Kaufman, HE.: Timolol, a beta-adrenergic blocking agent for the treatment of glaucoma. Archives of Ophthalmology 95: 601–604 (1977a). Zimmerman, T.J. and Kaufman, HE.: Timolol, dose response and duration of action. Archives of Ophthalmology 95: 605–607 (1977b). Zimmerman, T.J. and Kaufman, H.E.: Timolol, dose response and duration of action. Arch. Ophthalmol. 95: 605–607 (1977b).